A. For pregnancy, neurologists take many approaches to prevent Tysabri withdrawal relapses. I previously discussed in another blog tapering off Tysabri and monitoring for the return of disease activity before getting pregnant. I cannot argue with the use of IV Ig in this situation as well but recall that IV Ig treatment itself is controversial in MS patients. The majority of studies suggest minimal benefit from this treatment, so I would not expect it to have much of a benefit in this situation. However, it is relatively safe in this situation and I think it is the safety of IV Ig that is dictating its use in this setting, not its effectiveness.
PLEASE NOTE: The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and treatment. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.